#HaemOncID

“It's a risk-benefit analysis”: Qualitative perspectives on barriers and enablers to post-treatment vaccination from adults affected by a haematological malignancy in Australia People affected by haematological malignancies are at high risk of morbidity and mortality caused by vaccine-preventable infections. However, vaccinat…

What drives or discourages our haematology patients from getting vaccinated. Lovely collab with HSR team @petermaccc.bsky.social

www.sciencedirect.com/science/arti...
#TxID #HaemOncID